1995
DOI: 10.1016/0091-3057(95)00074-7
|View full text |Cite
|
Sign up to set email alerts
|

The NMDA receptor and cocaine: Evidence that MK-801 can induce behavioral sensitization effects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
14
0

Year Published

1996
1996
2013
2013

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(16 citation statements)
references
References 27 publications
2
14
0
Order By: Relevance
“…Abekawa et al (2007) prenatally treated rats with MK-801; however, it was shown that prenatal exposure to MK-801 neither enhanced the acute eff ects of methamphetamine on postnatal day 35 nor the development of behavioural sensitisation to methamphetamine. Carey et al (1995) found that an NMDA receptor antagonist enhanced behavioural responses evoked by drug stimuli (cocaine) and in this way promoted behavioural sensitisation in rats, which is consistent with our results obtained in the group n 4 where repeated co-administration of methamphetamine + felbamate resulted, after the methamphetamine challenge dose, in the development of behavioural sensitisation to the stimulatory eff ects of methamphetamine.…”
Section: Discussionsupporting
confidence: 82%
“…Abekawa et al (2007) prenatally treated rats with MK-801; however, it was shown that prenatal exposure to MK-801 neither enhanced the acute eff ects of methamphetamine on postnatal day 35 nor the development of behavioural sensitisation to methamphetamine. Carey et al (1995) found that an NMDA receptor antagonist enhanced behavioural responses evoked by drug stimuli (cocaine) and in this way promoted behavioural sensitisation in rats, which is consistent with our results obtained in the group n 4 where repeated co-administration of methamphetamine + felbamate resulted, after the methamphetamine challenge dose, in the development of behavioural sensitisation to the stimulatory eff ects of methamphetamine.…”
Section: Discussionsupporting
confidence: 82%
“…Our behavioral results also showed a non-significant trend to increase the d-AMPH response 8 days following one injection of MK-801 in the No Stress group. It has been reported that repeated MK-801 treatment increases locomotor activity and can develop sensitization to its own injection (Carey et al, 1995;Segal et al, 1995;Sripada et al, 1998;Vanderschuren et al, 1997;Wolf and Khansa, 1991). However, when MK-801 is coadministered with AMPH, the development of sensitization was blocked suggesting that MK-801 itself produces sensitization through a different mechanism than AMPH (Wolf and Khansa, 1991).…”
Section: Discussionmentioning
confidence: 82%
“…As with PCP, MK801 induces large neuronal vacuoles (Olney's lesions) within 30 min of administration [39]. Furthermore, MK801 paradoxically induces behavioral sensitization and place preference to itself, while blocking the development of these behaviors to other drugs [28,34,[40][41][42][43][44]. Thus, it is difficult to interpret the chronic behavioral effects of co-administering MK801 with psychostimulants as anything other than ambiguous.…”
Section: Introductionmentioning
confidence: 90%